Skip to content

EPS (Basic) at other companies

ARD
Ardent Health PartnersARDT
$0.28-6.7%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$0.39+200%
ICU Medical logo
ICU MedicalICUI
$1.22+294%
Universal Health Services logo
Universal Health ServicesUHS
$5.71+17.2%
Tenet Healthcare logo
Tenet HealthcareTHC
$8.09+87.7%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$0.85-30.9%

Other financials

Income statement

See full
Revenue$476.2M+3.9%
Operating income$41.7M+29.8%
Net income$29.6M+42.6%
EPS (diluted)$0.36+50.0%

Balance sheet

See full
Cash & equivalents$205.8M+108%
Total debt$629.7M-3.9%
Total equity$878.6M+11.3%
Total assets$2.1B+3.9%

Cash flow

See full
Operating cash flow-$129.8M-10.5%
CapEx$6.2M+88.3%
Free cash flow-$136.1M-12.7%

Valuation

See full
Market cap$1.99B+42.9%
Enterprise value$2.41B+22.3%
P/E11.4×
P/S+0.3×

Profitability

See full
Operating margin11.3%
Net margin9%
FCF margin12.3%+2.5pp

Returns & leverage

See full
Return on equity20.9%
Debt / equity0.7×-0.1×
Current ratio1.3×-0.5×

Where this comes from

Reported directly by Pediatrix Medical Group in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Pediatrix Medical Group’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pediatrix Medical Group's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pediatrix Medical Group's EPS (basic)?
Pediatrix Medical Group (MD) reported EPS (basic) of $0.37 in Q1 2026.
How has Pediatrix Medical Group's EPS (basic) changed year-over-year?
Pediatrix Medical Group's EPS (basic) increased by 48.0% year-over-year, from $0.25 to $0.37.
What is the long-term trend for Pediatrix Medical Group's EPS (basic)?
Over 3 years (2021 to 2025), Pediatrix Medical Group's EPS (basic) has grown at a 8.6% compound annual growth rate (CAGR), from $1.54 to $1.97.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.